Sven G. Meuth

Sven G. Meuth

Department of Neurology, University of Münster

Affiliated withUniversity of MünsterUniversity Hospital MünsterUniversity of Muenster

+2

Research Area

Immunology and InfectionNeuroscience

Biography

Sven G. Meuth has not added Biography.
If you are Sven G. Meuth and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 6
Year
Myelin Oligodendrocyte Glycoprotein (MOG<sub>35-55</sub>) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice
Publication title

Cited by 169

2014
Isolation of Primary Murine Brain Microvascular Endothelial Cells
Publication title

Cited by 110

2014
2015
2016
2019

Other Publications

Article
Year
Contribution of TWIK-related acid-sensitive K+ channel 1 (TASK1) and TASK3 channels to the control of activity modes in thalamocortical neurons.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 12878686

2003
Modulation of neuronal activity by the endogenous pentapeptide QYNAD.

The European journal of neuroscience| PubMed ID: 14656318

2003
2005
2006
2006
2006
2006
2007
2007
2007
2008
2008
Muscarinic ACh receptor-mediated control of thalamic activity via G(q)/G (11)-family G-proteins.

Pflügers Archiv : European journal of physiology| PubMed ID: 18350314

2008
2008
Reciprocal modulation of I (h) and I (TASK) in thalamocortical relay neurons by halothane.

Pflügers Archiv : European journal of physiology| PubMed ID: 18478257

2008
Detrimental contribution of the immuno-inhibitor B7-H1 to rabies virus encephalitis.

Journal of immunology (Baltimore, Md. : 1950)| PubMed ID: 18490751

2008
2008
The trials and errors in MS therapy.

International MS journal / MS Forum| PubMed ID: 18808741

2008
2008
2009
2009
Transient widespread blood-brain barrier alterations after cerebral photothrombosis as revealed by gadofluorine M-enhanced magnetic resonance imaging.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism| PubMed ID: 18957988

2009
2009
Recent clinical trials and future therapies.

Journal of neurology| PubMed ID: 19300967

2008
2009
2009
CD8+ T cells and neuronal damage: direct and collateral mechanisms of cytotoxicity and impaired electrical excitability.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology| PubMed ID: 19567369

2009
2009
2009
2010
2009
Cytotoxic CD8+ T cell-neuron interactions: perforin-dependent electrical silencing precedes but is not causally linked to neuronal cell death.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 20007464

2009
2010
2010
2010
Inhibition of bradykinin receptor B1 protects mice from focal brain injury by reducing blood-brain barrier leakage and inflammation.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism| PubMed ID: 20197781

2010
2010
2010
From the background to the spotlight: TASK channels in pathological conditions.

Brain pathology (Zurich, Switzerland)| PubMed ID: 20529081

2010
2010
Therapeutic approaches to multiple sclerosis: an update on failed, interrupted, or inconclusive trials of immunomodulatory treatment strategies.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy| PubMed ID: 20623991

2010
Two pore domain potassium channels in cerebral ischemia: a focus on K2P9.1 (TASK3, KCNK9).

Experimental & translational stroke medicine| PubMed ID: 20646278

2010
2010
2010
2010
2010
Natalizumab restores evoked potential abnormalities in patients with relapsing-remitting multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)| PubMed ID: 21135021

2011
2011
2011
2010
2011
2011
2011
A-type K+ currents in intralaminar thalamocortical relay neurons.

Pflügers Archiv : European journal of physiology| PubMed ID: 21437601

2011
2011
Ion channels in autoimmune neurodegeneration.

FEBS letters| PubMed ID: 21501610

2011
2012
2011
Knock-out of the potassium channel TASK-1 leads to a prolonged QT interval and a disturbed QRS complex.

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology| PubMed ID: 21865850

2011
Immunological and clinical consequences of treating a patient with natalizumab.

Multiple sclerosis (Houndmills, Basingstoke, England)| PubMed ID: 21908480

2012
2012
2012
2012
2011
2012
2012
2012
2012
2012
2012
Blocking of bradykinin receptor B1 protects from focal closed head injury in mice by reducing axonal damage and astroglia activation.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism| PubMed ID: 22569191

2012
Immune therapy of multiple sclerosis--future strategies.

Current pharmaceutical design| PubMed ID: 22612746

2012
2012
2012
2012
2012
2013
2013
2013
2012
2013
2013
2013
Get the rhythm: modeling neuronal activity.

Journal of undergraduate neuroscience education : JUNE : a publication of FUN, Faculty for Undergraduate Neuroscience| PubMed ID: 23493337

2005
2013
2013
2013
2013
2013
Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 23959874

2013
Targeting ion channels for the treatment of autoimmune neuroinflammation.

Therapeutic advances in neurological disorders| PubMed ID: 23997817

2013
2013
2013
2013
2013
2013
2013
2013
2013
TREK-King the Blood-Brain-Barrier.

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology| PubMed ID: 24557892

2014
Glatiramer acetate does not protect from acute ischemic stroke in mice.

Experimental & translational stroke medicine| PubMed ID: 24576335

2014
2014
Blocking of α4 integrin does not protect from acute ischemic stroke in mice.

Stroke; a journal of cerebral circulation| PubMed ID: 24743435

2014
Human CD4+ HLA-G+ regulatory T cells are potent suppressors of graft-versus-host disease in vivo.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology| PubMed ID: 24744146

2014
2014
2014
2014
2014
2014
2014
2015
2014
CD28 superagonist-mediated boost of regulatory T cells increases thrombo-inflammation and ischemic neurodegeneration during the acute phase of experimental stroke.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism| PubMed ID: 25315859

2015
The two-pore domain potassium channel KCNK5 deteriorates outcome in ischemic neurodegeneration.

Pflugers Archiv : European journal of physiology| PubMed ID: 25315980

2014
The role of two-pore-domain background K⁺ (K₂p) channels in the thalamus.

Pflugers Archiv : European journal of physiology| PubMed ID: 25346156

2015
Immunotherapy of multiple sclerosis.

Acta neuropsychiatrica| PubMed ID: 25384864

2009
The CNS under pathophysiologic attack-examining the role of K2P channels.

Pflugers Archiv : European journal of physiology| PubMed ID: 25482672

2014
2014
Long-term efficacy of alemtuzumab in polymyositis.

Rheumatology (Oxford, England)| PubMed ID: 25552256

2014
2015
2015
2014
2015
2015
2015
2016
2015
2015
2015
2015
2015
2015
2015
Blood-brain barrier modeling: challenges and perspectives.

Neural regeneration research| PubMed ID: 26199600

2015
Alemtuzumab in Multiple Sclerosis: Mechanism of Action and Beyond.

International journal of molecular sciences| PubMed ID: 26204829

2015
2015
2015
2015
2015
The role of ion channels in malignant brain tumors.

Journal of neuro-oncology| PubMed ID: 26334315

2015
2015
2015
Early and Degressive Putamen Atrophy in Multiple Sclerosis.

International journal of molecular sciences| PubMed ID: 26404239

2015
Effects of diazoxide in multiple sclerosis: A randomized, double-blind phase 2 clinical trial.

Neurology(R) neuroimmunology & neuroinflammation| PubMed ID: 26405686

2015
PML risk stratification using anti-JCV antibody index and L-selectin.

Multiple sclerosis (Houndmills, Basingstoke, England)| PubMed ID: 26432858

2016
2016
2015
2015
2015
2016
2015
2015
2016
2016
2016
2016
2016
2016
2016
Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 27162345

2016
2016
Evidence of a pathogenic role for CD8(+) T cells in anti-GABAB receptor limbic encephalitis.

Neurology(R) neuroimmunology & neuroinflammation| PubMed ID: 27213174

2016
2016
2016
2016
2016
2016
2016
2016
2016
2016
2016
Tau Tubulin Kinase TTBK2 Sensitivity of Glutamate Receptor GluK2.

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology| PubMed ID: 27607061

2016
Platelet derived FasL contributes to apoptosis in stroke.

Thrombosis and haemostasis| PubMed ID: 27608763

2016
B7-H1 shapes T-cell-mediated brain endothelial cell dysfunction and regional encephalitogenicity in spontaneous CNS autoimmunity.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 27671636

2016
2016
14-3-3 Proteins regulate K2P 5.1 surface expression on T lymphocytes.

Traffic (Copenhagen, Denmark)| PubMed ID: 27743426

2016
2016
Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis.

Neurology(R) neuroimmunology & neuroinflammation| PubMed ID: 27766281

2016
2016
2016
2016
2016
2017
2018
In Vitro Analyses of Novel HCN4 Gene Mutations.

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology| PubMed ID: 30196304

2018
2019
2018
2019
2021
Teriflunomide treatment is associated with optic nerve recovery in early multiple sclerosis.

Therapeutic advances in neurological disorders| PubMed ID: 33747129

2021
Impact of Diverse Ion Channels on Regulatory T Cell Functions.

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology| PubMed ID: 34043301

2021
Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19.

Neurology(R) neuroimmunology & neuroinflammation| PubMed ID: 34261812

2021
2022
2022
Thinking outside the box: non-canonical targets in multiple sclerosis.

Nature reviews. Drug discovery| PubMed ID: 35668103

2022
2022
2022
2022
2022
2022
Myositis in Germany: epidemiological insights over 15 years from 2005 to 2019.

Neurological research and practice| PubMed ID: 36581896

2022
2023
2023
2023
2023